Internet-CBT for Gambling Disorder - a Randomized Controlled Trial

Status Recruiting

Clinical Trial Summary

The study is a randomized controlled trial (Total N=150; each condition n=75) of internet-based cognitive behavioral therapy (iCBT), with measures at pre, weekly during treatment, post, three and at six month follow-up. Participants will be assigned to either standard iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition).

Clinical Trial Description

Recruitment will be done through online advertisement via social media and gambling-related websites. Participants will self-referred to the study via a study dedicated website (www.spelstudien.se). Login to a treatment platform will be verified using double authentication (detailed description of the online platform is provided in the application to the Swedish Ethical Review Authority). Written information about the study will be provided on the web page. Consent will be done online, with the possibility for participants to download study information and consent. Consenting participants will start a screening procedure. After screening, participants will be contacted for a telephone assessment with a clinical psychologist. During this interview, participants will be assessed for GD with a diagnostic interview, as well as the inclusion criteria for utilization of "Spelpaus". If meeting criteria for the study, participants will be referred to the baseline/pre-measures - which will start with an additional informed consent for the treatment phase and the iCBT. Inclusion will be done after the completion of the informed consent and baseline/pre-measures. After that, participant will be randomized to iCBT and "Spelpaus" (treatment condition), or "Spelpaus" only (control condition). Randomization will be conducted by a third party using a true random service, https://random.org. Participants assigned to the control condition in the randomized controlled trial will receive a voucher of total 1000 Swedish Krona's when completing the post and follow up measures. Participants assigned to the control condition in the randomized controlled trial will receive a voucher of total 1000 Swedish Krona's when completing the post and follow up measures. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06099522
Study type	Interventional
Source	Karolinska Institutet
Contact	Olof Molander, PhD
Phone	0700011241
Email	olof.molander@ki.se
Status	Recruiting
Phase	N/A
Start date	January 15, 2024
Completion date	June 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03614884` - Effectiveness of an Online Integrated Treatment for Problem Gambling and Tobacco Smoking	N/A
Completed	`NCT03946098` - ICBTG in Routine Care	N/A
Completed	`NCT03725735` - Emotion Regulation Group Treatment for Gambling Disorder - a Pilot Trial	N/A
Not yet recruiting	`NCT05331612` - Blended Treatment for Problem Gambling and Gambling Disorder Combining Group Sessions and Online Modules	N/A
Completed	`NCT03145792` - Online Coping Skills Counseling for Problem Gambling and Trauma	N/A
Not yet recruiting	`NCT03280966` - Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder	Phase 2
Recruiting	`NCT02953899` - Contingency Management as an Adjunct Treatment for Rural and Remote Disordered Gamblers	N/A
Recruiting	`NCT05686772` - Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis
Recruiting	`NCT03336879` - Repetitive Transcranial Magnetic Stimulation in Gambling Disorder	N/A
Recruiting	`NCT05413564` - Impact of a Self-Exclusion Procedure Optimized by an Extension of the Suspension of Commercial Solicitations	N/A
Recruiting	`NCT03669315` - Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation	Phase 3
Recruiting	`NCT05833503` - Integrative Couple Treatment for Gambling/Substance Use Disorder	N/A
Completed	`NCT03477799` - The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder	Phase 3
Active, not recruiting	`NCT03497247` - Mindfulness-Based Cognitive-Behavioral Therapy for Gambling Disorder	N/A
Recruiting	`NCT04646421` - Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden.
Completed	`NCT03354702` - Physical Activity Pathological Gamblers	N/A
Completed	`NCT03287583` - SBIRT Intervention for Gambling Behaviors	N/A
Not yet recruiting	`NCT04158037` - Don't Go There: A Geospatial mHealth App for Gambling Disorder	N/A
Not yet recruiting	`NCT06467422` - Effects of Transcranial Temporal Interference Stimulation on Risky Decision-making and Impulse Control in Gambling Disorder	N/A
Not yet recruiting	`NCT04738773` - RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.